Pain Coping Skills Training for Patients Receiving Hemodialysis: The HOPE Consortium Randomized Clinical Trial

医学 简短疼痛清单 随机对照试验 物理疗法 血液透析 心理干预 焦虑 生活质量(医疗保健) 慢性疼痛 透析 内科学 精神科 护理部
作者
Laura M. Dember,Jesse Y. Hsu,Rajnish Mehrotra,Kerri L. Cavanaugh,Sahir Kalim,David M. Charytan,Michael J. Fischer,Manisha Jhamb,Kirsten L. Johansen,William C. Becker,Bethany S. Pellegrino,Nwamaka D. Eneanya,Sarah J. Schrauben,Patrick H. Pun,Mark L. Unruh,Benjamin J. Morasco,Mansi Mehta,Nobuyuki Miyawaki,Jeffrey G. Penfield,Leah Bernardo
出处
期刊:JAMA Internal Medicine [American Medical Association]
卷期号:185 (2): 197-197 被引量:44
标识
DOI:10.1001/jamainternmed.2024.7140
摘要

Importance: Chronic pain is common among individuals with dialysis-dependent kidney failure. Objective: To evaluate the effectiveness of pain coping skills training (PCST), a cognitive behavioral intervention, on pain interference. Design, Setting, and Participants: This multicenter randomized clinical trial of PCST vs usual care was conducted across 16 academic centers and 103 outpatient dialysis facilities in the US. Adults undergoing maintenance hemodialysis and experiencing chronic pain were randomly assigned to PCST or usual care in a 1:1 ratio. Participants were followed in the trial for 36 weeks. Enrollment began on January 4, 2021, and follow-up ended on December 21, 2023. Interventions: PCST consisting of 12 weekly coach-led sessions via video or telephone conferencing, followed by 12 weeks of daily interactive voice response sessions. Usual care had no trial-driven pain intervention. Main Outcomes: The primary outcome was pain interference measured with the Brief Pain Inventory (BPI) Interference subscale (score range of 0-10, with higher scores indicating more pain interference). Secondary outcomes included pain intensity, pain catastrophizing, quality of life, depression, and anxiety. Results: A total of 643 participants (mean [SD] age, 60.3 [12.6] years; 288 [44.8%] female) were randomized, with 319 assigned to PCST and 324 assigned to usual care. At week 12 (primary end point), the PCST group had a larger reduction in the BPI Interference score than the usual care group (between-group difference, -0.49; 95% CI, -0.85 to -0.12; P = .009). The effect persisted at week 24 (between-group difference in BPI Interference score, -0.48; 95% CI, -0.86 to -0.11) but was diminished at week 36 (between-group difference in BPI Interference score, -0.34; 95% CI, -0.72 to 0.04). A decrease in BPI Interference score greater than 1 point (minimal clinically important difference) occurred in 143 of 281 participants (50.9%) in the PCST group vs 108 of 295 participants (36.6%) in the usual care group at 12 weeks (odds ratio, 1.79; 95% CI, 1.28-2.49) and 142 of 258 participants (55.0%) in the PCST group vs 113 of 264 participants (42.8%) in the usual care group at 24 weeks (odds ratio, 1.59; 95% CI, 1.13-2.24). Favorable changes with PCST were also apparent for secondary outcomes of pain intensity, quality of life, depression, and anxiety at weeks 12 and/or 24, as well as for pain catastrophizing at weeks 24 and 36. Conclusions and Relevance: In this randomized clinical trial of patients undergoing maintenance hemodialysis, PCST had benefits on pain interference and other pain-associated outcomes. While the effect on the overall cohort was of modest magnitude, the intervention resulted in a clinically meaningful improvement in pain interference for a substantial proportion of participants. Trial Registration: ClinicalTrials.gov Identifier: NCT04571619.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yaoyaoya发布了新的文献求助10
刚刚
Jack_20708124完成签到 ,获得积分10
刚刚
1秒前
1秒前
WZJ发布了新的文献求助10
1秒前
luo完成签到,获得积分10
2秒前
3秒前
3秒前
无花果的应助被盒子采纳,获得10
5秒前
6秒前
6秒前
gAle完成签到 ,获得积分10
6秒前
红莲墨生发布了新的文献求助10
7秒前
Ava的应助被无敌干扰素采纳,获得30
8秒前
共享精神的应助被小卢采纳,获得10
9秒前
369ninja发布了新的文献求助10
9秒前
AireenBeryl531举报笑笑的求助涉嫌违规
10秒前
Akim的应助被普鲁卡因采纳,获得10
11秒前
12秒前
daomaihu发布了新的文献求助100
12秒前
今后的应助被马大海采纳,获得10
12秒前
worldlet发布了新的文献求助10
12秒前
田様的应助被科研通管家采纳,获得10
12秒前
科目三的应助被科研通管家采纳,获得10
13秒前
无花果的应助被科研通管家采纳,获得10
13秒前
fan的应助被科研通管家采纳,获得10
13秒前
充电宝的应助被科研通管家采纳,获得10
13秒前
null的应助被科研通管家采纳,获得10
13秒前
脑洞疼的应助被科研通管家采纳,获得10
13秒前
小蘑菇的应助被科研通管家采纳,获得10
13秒前
null的应助被科研通管家采纳,获得10
13秒前
TH发布了新的文献求助30
13秒前
Akim的应助被科研通管家采纳,获得10
14秒前
赘婿的应助被科研通管家采纳,获得10
14秒前
inspire的应助被科研通管家采纳,获得10
14秒前
14秒前
大个的应助被科研通管家采纳,获得10
14秒前
14秒前
14秒前
余香的应助被科研通管家采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184336
求助须知:如何正确求助?哪些是违规求助? 9573358
关于积分的说明 21830993
捐赠科研通 7781367
什么是DOI,文献DOI怎么找? 3434307
关于科研通互助平台的介绍 2558401
邀请新用户注册赠送积分活动 2480846